Spondin-2 is a novel diagnostic biomarker for laryngeal squamous cell carcinoma

In conclusion, spondin-2 might be a novel therapeutic target and prognostic biomarker for LSCC patients.
Source: Pathology Research and Practice - Category: Pathology Source Type: research